09 August 2023 By DAVID NIELD The vaccine counters the virus and stops it evolving. (QIMR Berghofer Medical Research Institute) Researchers have made a significant breakthrough in the development of the first-ever vaccine for the Epstein-Barr virus (EBV), a virus that causes infectious mononucleosis (IM, or ‘mono’) – also known as glandular fever. The virus can infamously lead to further health issues like cancer and multiple sclerosis (MS)....
